PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia · Acute Myeloid Leukemia Refractory · Acute Myeloid Leukemia, in Relapse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Seattle Children's Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Adam Lamble, MD) · CBDCIntake@seattlechildrens.org
    Contact: Principal Investigator (Adam Lamble, MD)